Ticker AEMD – Aethlon Medical Inc – sales, description, marketcap – Tickerday.com

AEMD

Aethlon Medical Inc

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 17.02M; Volume: 45.94K; AvgVol 3m: 385.90K; Beta: 0.35;

Cost estimate:

P/E: –; EPS: -1.94; EPS growth quarter/prev quarter: 91.00%;

EPS growth this year: 63.60%; EPS growth past 5 years: 36.60%;

EPS ttm: -1.94;

P/S: 25.72; P/B: 0.82; P/Cashflow: 0.98; P/FCF: ;

Sales: 620.00K; Sales growth quarter/prev quarter: ; Sales growth past 5 years: -3.10%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -69.80%; ROE – return on equity: -79.40%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.20%; Insider Transactions:0.00%;

Institutional Ownership: 10.20%; Institutional Transactions: 1.01%;

Data update: 07.10.2020.